Skip to content

Elise Kayson-Rubin, NP, MS

Not Accepting New Patients

Contact

Appointment (585) 275-4696

About Me

Certified Specialties

Nurse Practitioner, Adult Health - American Nurses Credentialing Center

Faculty Appointments

Adjunct Instructor - Department of Neurology (SMD)

Credentials

Residency & Fellowship

Graduate, Alfred University.

Graduate, Monroe Community College.

Education

NP | University of Rochester. Nurse Practitioner. 0

Publications

Journal Articles

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C

JAMA neurology.. 2016 January 73 (1):102-10. Epub 1900 01 01.

Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.

Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, Shoulson I

Neurology.. 2013 May 2880 (22):2022-7. Epub 04/26/2013.

A randomized, placebo-controlled trial of latrepirdine in Huntington disease.

Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, Seely L, Walker F, Feigin A, ,

Archives of neurology.. 2010 February 67 (2):154-60. Epub 1900 01 01.

Fear of health insurance loss among individuals at risk for Huntington disease.

Oster E, Dorsey ER, Bausch J, Shinaman A, Kayson E, Oakes D, Shoulson I, Quaid K,

American journal of medical genetics. Part A.. 2008 August 15146A (16):2070-7. Epub 1900 01 01.

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.

Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M,

Journal of neurology, neurosurgery, and psychiatry.. 2008 August 79 (8):874-80. Epub 12/20/2007.

Longitudinal analysis of the UHDRS in individuals at risk for Huntington's disease

Biglan K, Zhao, Oakes D, Kayson E, Shoulson I and the Huntington Study Group PHAROS Investigators.

Annals of Neurology. 2008; 64 (Suppl 12)(Suppl 12): A69.

Five years of monitoring the safety and feasibility of PHAROS

Kayson EP and Huntington Study Group PHAROS Investigators (Prospective Huntington At Risk Observational Study).

Neurotherapeutics. 2008; Volume 5(Issue 2): 366.

Influence of insurance on the decision to pursue genetic testing in individuals at risk for Huntington's Disease

Oster E, Dorsey ER, Bausch J, Shinaman A, Kayson E, Oakes D, Shoulson I, Quaid K, and the Huntington Study Group PHAROS Investigators.

Neurotherapeutics. 2008; Volume 5(Issue 2): 368.

Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease.

Johnson SA, Stout JC, Solomon AC, Langbehn DR, Aylward EH, Cruce CB, Ross CA, Nance M, Kayson E, Julian-Baros E, Hayden MR, Kieburtz K, Guttman M, Oakes D, Shoulson I, Beglinger L, Duff K, Penziner E, Paulsen JS,

Brain : a journal of neurology.. 2007 July 130 (Pt 7):1732-44. Epub 1900 01 01.

Verbal episodic memory declines prior to diagnosis in Huntington's disease.

Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, Ross CA, Beglinger L, Hayden MR, Kieburtz K, Kayson E, Julian-Baros E, Duff K, Guttman M, Nance M, Oakes D, Shoulson I, Penziner E, Paulsen JS,

Neuropsychologia.. 2007 April 945 (8):1767-76. Epub 01/09/2007.

Preparing for preventive clinical trials: the Predict-HD study.

Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA, Guttman M, Nance M, Kieburtz K, Oakes D, Shoulson I, Kayson E, Johnson S, Penziner E,

Archives of neurology.. 2006 June 63 (6):883-90. Epub 1900 01 01.

Interrater agreement in the assessment of motor manifestations of Huntington's disease.

Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H

Movement disorders : official journal of the Movement Disorder Society.. 2005 March 20 (3):293-7. Epub 1900 01 01.

Predictors of nursing home placement in Huntington disease.

Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I,

Neurology.. 2003 March 2560 (6):998-1001. Epub 1900 01 01.

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.

Shoulson I, Penney J, McDermott M, Schwid S, Kayson E, Chase T, Fahn S, Greenamyre JT, Lang A, Siderowf A, Pearson N, Harrison M, Rost E, Colcher A, Lloyd M, Matthews M, Pahwa R, McGuire D, Lew MF, Schuman S, Marek K, Broshjeit S, Factor S, Brown D, Feigin A, Mazurkiewicz J, Ford B, Jennings D, Dilllon S, Comella C, Blasucci L, Janko K, Shulman L, Wiener W, Bateman-Rodriguez D, Carrion A, Suchowersky O, Lafontaine AL, Pantella C, Siemers E, Belden J, Davies R, Lannon M, Grimes D, Gray P, Martin W, Kennedy L, Adler C, Newman S, Hammerstad J, Stone C, Lewitt P, Bardram K, Mistura K, Miyasaki J, Johnston L, Cha JH, Tennis M, Panniset M, Hall J, Tetrud J, Friedlander J, Hauser R, Gauger L, Rodnitzky R, Deleo A, Dobson J, Seeberger L, Dingmann C, Tarsy D, Ryan P, Elmer L, Ruzicka D, Stacy M, Brewer M, Locke B, Baker D, Casaceli C, Day D, Florack M, Hodgeman K, Laroia N, Nobel R, Orme C, Rexo L, Rothenburgh K, Sulimowicz K, Watts A, Wratni E, Tariot P, Cox C, Leventhal C, Alderfer V, Craun AM, Frey J, McCree L, McDermott J, Cooper J, Holdich T, Read B,

Neurology.. 2001 February 2756 (4):455-62. Epub 1900 01 01.

Rate of functional decline in Huntington's disease. Huntington Study Group.

Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB, Siemers E, Shoulson I

Neurology.. 2000 January 2554 (2):452-8. Epub 1900 01 01.